Literature DB >> 15763342

The newly established human hepatocyte cell line: application for the bioartificial liver.

Norifumi Harimoto1, Akinobu Taketomi, Dai Kitagawa, Yousuke Kuroda, Shinji Itoh, Tomonobu Gion, Shinji Tanaka, Ken Shirabe, Mitsuo Shimada, Yoshihiko Maehara.   

Abstract

BACKGROUND/AIMS: Human hepatocyte cell lines are reported to lose many of their biochemical functions in a hybrid artificial liver support system (HALSS). Differentiation therapy is useful to up-regulate liver function.
METHODS: The human hepatoblastoma cell line HepG2 was transfected with HSV/tk gene. Albumin synthesis and ammonia removal activity were evaluated when HepG2/tk was cultured with histone deacetylase inhibitor (FR228) and peroxisome proliferator activated receptor-gamma ligand (pioglitazone). To investigate the function of HepG2/tk in vivo, cell transplantation for 90% hepatectonized rats was conducted.
RESULTS: We established stable cell lines which expressed HSV/tk and were sensitive to gancyclovir in vitro and in vivo. Both albumin synthesis rate and ammonia removal rate improved for HepG2/tk incubated with FR228 and pioglitazone for 3 days, which induced nuclear transport of p21. Rats with intrasplenic injection of HepG2/tk precultured for 3 days with FR228 and pioglitazone survived significantly longer than the control rats. The ammonia and total bilirubin concentrations were significantly lower in the test group than in the control group. The injection of gancyclovir inhibited the prolonged survival of the rats with precultured HepG2/tk.
CONCLUSIONS: HepG2/tk is safe as well as enhancing high levels of liver function. It will be a potential cell source for HALLS in the future.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763342     DOI: 10.1016/j.jhep.2004.11.038

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  2 in total

1.  Hybrid bioartificial liver support in cynomolgus monkeys with D-galactosamine-induced acute liver failure.

Authors:  Zhi Zhang; Yi-Chao Zhao; Yuan Cheng; Guo-Deng Jian; Ming-Xin Pan; Yi Gao
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

2.  Modifying three-dimensional scaffolds from novel nanocomposite materials using dissolvable porogen particles for use in liver tissue engineering.

Authors:  Hussamuddin Adwan; Barry Fuller; Clare Seldon; Brian Davidson; Alexander Seifalian
Journal:  J Biomater Appl       Date:  2012-04-24       Impact factor: 2.646

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.